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Abstract
Background: Racial and ethnic disparities in breast cancer incidence, stage at diagnosis, survival and mortality are
well documented; but few studies have reported on disparities in breast cancer treatment. This paper compares
the treatment received by breast cancer patients in British Columbia (BC) for three ethnic groups and three time
periods. Values for breast cancer treatments received in the BC general population are provided for reference.
Methods: Information on patients, tumour characteristics and treatment was obtained from BC Cancer Registry
(BCCR) and BC Cancer Agency (BCCA) records. Treatment among ethnic groups was analyzed by stage at diagnosis
and time period at diagnosis. Differences among the three ethnic groups were tested using chi-square tests, Fisher
exact tests and a multivariate logistic model.
Results: There was no significant difference in overall surgery use for stage I and II disease between the ethnic
groups, however there were significant differences when surgery with and without radiation were considered
separately. These differences did not change significantly with time. Treatment with chemotherapy and hormone
therapy did not differ among the minority groups.
Conclusion: The description of treatment differences is the first step to guiding interventions that reduce ethnic
disparities. Specific studies need to examine reasons for the observed differences and the influence of culture and
beliefs.
Background
Breast cancer is an important public health issue and
major cause of premature mortality in women around
the world. Globally, it accounts for 22% of all new can-
cer diagnoses in women, and approximately 10% of
cases in men and women combined. It represents 7% of
cancer-related deaths worldwide [1]. In Canada during
2009, breast cancer is estimated to be the most common
cancer in women, with more than 22,000 new diagnoses.
It is expected to kill more than 5,000 Canadian women
in 2009, more than any other type of cancer except
lung. One in nine women will be diagnosed with breast
cancer during 2009, and 1 in 27 will die from the dis-
ease. Breast cancer accounted for an estimated 95,300
potential years of life lost in Canada during 2009 [1].
Canada is becoming more racially and ethnically
diverse. Its immigrant population has increased substan-
tially, contributing to growing ethnic communities.
Racial and ethnic disparities in breast cancer incidence,
stage at diagnosis, survival and mortality are well docu-
mented [2]; however few studies have examined dispari-
ties in the treatment that breast cancer patients
received. It has been reported that African American,
Mexican and Puerto Rican breast cancer patients in the
United States (US) were less likely to receive the stan-
dard of care, whereas Asian and Pacific Islanders were
more likely to receive the standard of care [3]. Dispari-
ties in the management of early stage breast cancer have
been reported among Asian American and Pacific Islan-
ders, particularly among Japanese and Filipinos, and
African American breast cancer patients were signifi-
cantly less likely to receive radiation after lumpectomy
than white patients [4,5]. A study in North Carolina
found that African American women were less likely to
receive hormone therapy and more likely to receive che-
motherapy than white women, regardless of the stage at
diagnosis [6]. None of these studies reported a decrease
in the magnitude of racial disparities between 1992 and
2002.
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things, including socioeconomic factors, patient-physi-
cian interactions, and the patient’s beliefs and knowl-
edge. It is the responsibility of physicians to counsel
patients about their treatment options, although culture
and ethnicity may inhibit this.
Breast cancer is a common cancer in British Columbia
(BC) and provincial treatment guidelines have been in
effect for several years. This paper compares the treat-
ment received by breast cancer patients for three ethnic
g r o u p si nB C :C h i n e s e ,S o u t hA s i a n sa n dI r a n i a n s .
These groups correspond to large immigrant commu-
nities in the province. Treatment is compared during
three time periods: 1980-1989, 1990-1999 and 2000-
2006. Values for breast cancer treatments received in
the BC general population are provided for reference.
Methods
All women with histologically-confirmed breast cancer
diagnosed between 1980 and 2006 were identified from
the population-based BC Cancer Registry (BCCR). It is
estimated that more than 95% of all incident cancer
cases in BC are registered by the BCCR [7]. We chose
1980 as the starting point for this analysis because
immigration among South Asians and Iranians was low
before this, and substantial advances in treatment and a
provincial treatment guideline were made after 1980.
We restricted cases to patients who were referred to the
BC Cancer Agency (BCCA) because staging and treat-
ment information was only available in BCCA records.
Cases were classified as Chinese, South Asian or Iranian
using surname listings. Ethnicity is not recorded in
either BCCA or BCCR records. The methodology for
classifying ethnicity using surnames has been described
in previous papers [8,9]. A total of 3,009 breast cancer
cases were analyzed: 1,958 ethnic Chinese, 915 ethnic
South Asians and 136 ethnic Iranians.
Information was collected for each case regarding
patient characteristics (age at diagnosis, ethnicity and
date of diagnosis), tumor characteristics (stage and
extent of disease, and tumor size) and primary treat-
ment received (surgery, radiation, chemotherapy and
hormone therapy). We separated surgery into two cate-
gories depending on whether it was accompanied by
radiation. The Tumor, Nodes and Metastasis (TNM)
classification of the International Union Contra Cancer
(UICC) was used for staging [10].
Information on patient characteristics was obtained
from BCCR records that were compiled for a separate
research program on cross cultural issues. Information
on tumor characteristics and treatment was obtained
from BCCA records.
Frequency distributions and proportions of an ethnic
group receiving each treatment were calculated
according to breast cancer stage. Treatments received by
cases were analyzed both together and separately for
each diagnosis time period (1980-1989, 1990-1999 and
2000-2006). Differences between ethnic groups in the
treatments received were tested using chi-squared statis-
tics. Results for the general population are shown for
comparison. The general population includes the ethnic
groups, and thus values are not statistically independent
from them. Further, unlike values for the ethnic groups,
the general population values incorporate breast cancer
patients who were not referred to the BCCA for treat-
ment. This also limits formal comparisons involving the
general population. The persistence of ethnic disparities
over time (i.e., the interaction of ethnic group and time
period) was analyzed using a multivariate logistic model.
Analyses were conducted using SPSS (version 17),
declaring statistical significance when the p-value from a
two-sided test was less than 5%.
We received approval for the study from the UBC
BCCA Research Ethics Board. (UBC is the University of
British Columbia.)
Results
Basic characteristics of the study groups are shown in
Table 1. Age at diagnosis was not significantly asso-
ciated with ethnicity, although Iranian women tended to
be diagnosed at an earlier age than women of the two
other ethnicities. Further, 42.6%, 42.1% and 38.3% of Ira-
nian, Chinese and South Asian women were diagnosed
before age 50 years. There were no significant ethnic
group differences for time period of diagnosis, but there
was a very significant difference in the distribution of
stage for the three ethnic groups. Higher proportions of
Chinese and Iranians were diagnosed with stage I dis-
ease compared to South Asians. Conversely, higher per-
centages of South Asians were diagnosed with stage III
or IV breast cancer compared to patients in the Chinese
and Iranian groups. All of the specific ethnic groups
seem to have been diagnosed at an earlier age than the
BC general population, but readers are reminded that
the general population includes patients who were not
referred to the BCCA.
The types of treatment received among cases from the
ethnic groups are shown in Table 2. There were no sig-
nificant differences in overall surgery use for stage I and
II disease among the ethnic groups, however there were
significant differences when surgery with and without
radiation were considered separately. The appropriate-
ness of radiation usually depends on the type of surgery,
so it is difficult to untangle the use of radiation and sur-
gery. Compared to other ethnic groups, Chinese women
with stage I or stage II disease were least likely to
receive surgery with radiation. Conversely, Chinese
women with stage I or stage II disease were most likely
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Page 2 of 7Table 1 Number (%) of patients according to basic demographic and tumor characteristics, 1980-2006.
Ethnic Group
Chinese
(n = 1,958)
South Asian
(n = 915)
Iranian
(n = 136)
P-value General Population
Age at diagnosis (yrs)
Mean ± SD 54.9 ± 13.4 54.1 ± 12.2 52.7 ± 10.5 0.064 59.8 ± 13.5
Diagnosis year 0.261
1980-1989 216 (11.0) 119 (13.0) 11 (8.1) 9,274 (24.6)
1990-1999 805 (41.1) 353 (38.6) 61 (44.9) 14,928 (39.6)
2000-2006 937 (47.9) 443 (48.4) 64 (47.1) 13,478 (35.8)
Stage* <0.001
I 808 (45.9) 271 (32.6) 52 (43.7) 15,813 (42.0)
II 695 (39.5) 395 (47.5) 53 (44.5) 16,137 (42.8)
III 103 (5.9) 69 (8.3) 6 (5.0) 3,690 (9.8)
IV 153 (8.7) 97 (11.7) 8 (6.7) 2,040 (5.4)
* non-missing values only
Table 2 Number (%) of patients receiving treatment by stage at diagnosis, 1980-2006.
Ethnic Group
Stage* Treatment Chinese South Asian Iranian P-value General Population
I n = 808 n = 271 n = 52 n = 15,813
Radiation 481 (59.5) 191 (70.5) 39 (75.0) 0.001 10,476 (66.2)
Surgery 787 (97.4) 265 (97.8) 50 (96.2) 0.787 14,981 (94.7)
Surgery with radiation 477 (59.0) 189 (69.7) 37 (71.2) 0.003 10,266 (64.9)
Surgery without radiation 310 (38.4) 76 (28.0) 13 (25.0) 0.002 4,715 (29.8)
Chemotherapy 158 (19.6) 57 (21.0) 9 (17.3) 0.781 2,027 (12.8)
Hormone therapy 405 (50.1) 115 (42.4) 23 (44.2) 0.077 6,549 (41.4)
II n = 695 n = 395 n = 53 n = 16,137
Radiation 468 (67.3) 294 (74.4) 45 (84.9) 0.003 11,163 (69.2)
Surgery 667 (96.0) 380 (96.2) 53 (100.0) 0.331 14,784 (91.6)
Surgery with radiation 458 (65.9) 291 (73.7) 45 (84.9) 0.001 10,720 (66.4)
Surgery without radiation 209 (30.1) 89 (22.5) 8 (15.1) 0.004 4,064 (25.2)
Chemotherapy 455 (65.5) 260 (65.8) 41 (77.4) 0.208 7,503 (46.5)
Hormone therapy 408 (58.7) 236 (59.7) 31 (58.5) 0.942 9,363 (58.0)
III n = 103 n = 69 n = 6 n = 3,690
Radiation 91 (88.3) 62 (89.9) 6 (100.0) 0.657 3,124 (84.7)
Surgery 95 (92.2) 64 (92.8) 6 (100.0) 0.777 2,921 (79.2)
Surgery with radiation 84 (81.6) 60 (87.0) 6 (100.0) 0.355 2,634 (71.4)
Surgery without radiation 11 (10.7) 4 (5.8) 0 (0.0) 0.397 287 (7.8)
Chemotherapy 87 (84.5) 57 (82.6) 6 (100.0) 0.531 2,449 (66.4)
Hormone therapy 75 (72.8) 40 (58.0) 4 (66.7) 0.128 2,199 (59.6)
IV n = 153 n = 97 n = 8 n = 2,040
Radiation 119 (77.8) 77 (79.4) 6 (75.0) 0.931 1,437 (70.4)
Surgery 93 (60.8) 58 (59.8) 4 (50.0) 0.830 878 (43.0)
Surgery with radiation 79 (51.6) 47 (48.5) 3 (37.5) 0.685 643 (31.5)
Surgery without radiation 14 (9.2) 11 (11.3) 1 (12.5) 0.832 235 (11.5)
Chemotherapy 95 (62.1) 59 (60.8) 5 (62.5) 0.979 867 (42.5)
Hormone therapy 95 (62.1) 62 (63.9) 5 (62.5) 0.958 1,302 (63.8)
* non-missing values only
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other ethnic groups. For both surgery with and without
radiation, the interaction between ethnicity and time
period was not significant at any disease stage. The pro-
portions of stage I and stage II breast cancer patients
that received surgery with radiation for each time period
is shown in Figure 1. Compared to other ethnic groups,
the proportion of Chinese women that received surgery
with radiation therapy was lowest during all time
periods.
There were no significant ethnic group differences for
other types of treatment at any disease stage. All of the
specific ethnic groups seem to have received more che-
motherapy than the BC general population for each dis-
ease stage, and ethnic groups sometimes seem to have
received more hormone therapy than the BC general
population. Readers are reminded that the general popu-
lation includes patients who were not referred to the
BCCA.
Discussion
Breast cancer is predominantly a disease of the econom-
ically developed world, but rates are rising rapidly in
Asia and economically developing countries. Ethnic
differences exist in the distribution of breast cancer his-
tological types, regardless of country of residence. For
example, there is a greater incidence of basal type breast
cancer within African-American and West African
populations [11]. Ethnic differences also exist in breast
cancer survival outcomes. An earlier study in BC found
that Chinese women had higher breast cancer survival
rates than either South Asian women or the female gen-
eral population. It was speculated that these survival dif-
ferences may be due to differences in treatment
practices and possibly cancer biology because the
screening rates were similar among the three population
groups [12].
The National Academy of Sciences reported that racial
and ethnic minorities generally receive lower quality
healthcare than non-minorities [13]. Differences in treat-
ment are known to occur in breast cancer patients of
different racial and ethnic groups. A number of factors
contribute to this observation, including the types of
treatment being offered, the ages of the women exam-
ined, and the location of the study. Most studies have
compared African American and white women. For
example, in some studies breast-conserving surgery was
more frequently given to African American women,
whereas radiation therapy following breast-conserving
surgery was more frequently given to white women [13].
We found that South Asian women with breast cancer
tended to be diagnosed at more advanced stages than
other women. Previous studies in the US have shown
that African Americans, American Indians and Hispanic
Whites present with more advanced stages of breast
cancer [14-24]. Li and colleagues [3] provided some of
the first evidence that Indians and Pakistanis, Mexicans,
South and Central Americans, and Puerto Ricans are
more likely to present with advanced stages of breast
cancer in the US. Poorer survival rates and the more
advanced disease stages among these women were
attributed to differences in mammography use, obesity
and tumor marker expression. Another US study found
that differences in staging between African Americans
and whites are present among nonusers of mammogra-
phy but not among regular users [25]. Our study would
suggest the need for increased breast cancer screening
for South Asian women, so that more cancer cases can
be diagnosed at an earlier stage, when treatment is more
effective. However, the proportions of women receiving
screening mammography in BC who are South Asian or
Chinese are similar to those in the BC general popula-
tion [12].
We found that Chinese women are significantly less
likely to receive radiation therapy than South Asian and
Iranian women, but this is probably explained by the
ethnic groups’ differing use of radiation accompanying
surgery. The use of chemotherapy or hormone therapy
Figure 1 Proportions of stage I and stage II breast cancer
patients in BC that received surgery with radiation, according
to ethnic group and time period.
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qualitative study examined treatment decision making in
a small group of BC Chinese women with in situ breast
cancer and reported a primary treatment goal was to be
rid of their cancer; hence mastectomy was considered to
be the treatment of choice [26]. Other treatment
options, including breast conserving surgery (which
would include radiation), were viewed as less effective
options because it would only “control the situation” for
a limited period of time [26]. We cannot be certain
whether the preference for mastectomy over breast-con-
serving surgery occurred in our study’s patients. A stan-
dard treatment protocol for breast cancer patients in BC
is determined mainly by the patient’s age, type and stage
of cancer, tumour sensitivity to certain hormones, and
the tumour’se x p r e s s i o no ft h eg e n eH E R 2 .H o w e v e r ,
patient preference in treatment choice might be contri-
buting to the ethnic differences observed in our study.
Future work in examining ethnic group disparities in
treatment should not overlook patient preferences.
Other studies also have shown differences in treat-
ments received between ethnic groups. African Ameri-
cans have been found to be less likely to receive optimal
treatment for early or advanced stage disease compared
to whites [3]. Cost of treatment may be a contributing
factor because African American and Hispanic patients
in the US were reported to be more likely to have insur-
ance when compared to non-Hispanic white patients
[27]. Some reports suggest no difference in the rates of
breast conserving surgery between indigent and well
insured populations, whereas other studies suggest that
economic status influence the treatment received [27].
However, where there is socialized health care, the eco-
nomic status of the patient has less influence on treat-
ment delivery. European studies with socialized
healthcare report that patients with poorer socioeco-
nomic backgrounds are treated as aggressively as weal-
thier patients [28]. In the US, patients receiving care
within health maintenance organizations, for whom
costs are internalized similar to socialized care, may be
more motivated to consider downstream costs when
making decisions on the initial treatment of breast can-
cer [29]. In BC, residents receive universal health care
coverage and thus costs should not be a determining
factor for the choice of treatment.
Recent data suggest that certain patients can omit post-
operative radiation therapy after learning the risk and ben-
efits of treatment [27]. Mandelbatt and colleagues have
reported that older African American women are twice as
likely as white women to have a radiotherapy omitted [30].
Patient’s age, stage of disease, co-morbidity/life expec-
tancy, physical functioning and cancer biology all influence
the recommendation for chemotherapy. Studies
have reported that the likelihood of receiving a
recommendation for chemotherapy decreases by 91% per
each 10-year age interval [31]. Ethnic groups might
include a large proportion of immigrants, and it is unclear
whether ethnic groups, and immigrants in particular, have
a different likelihood of co-morbidity than others in the
population. A difference could explain different use of
treatments among the various ethnic groups.
We did not consider survival or other outcomes in
this analysis. Survival analyses are often inappropriate in
the analysis of retrospective data because of “confound-
ing by indication”, where treatments appear to affect
survival but actually reflect treatment use that is based
on the survival expectation for a patient.
This study had many strengths. Importantly, the data
was population-based and abstracted from the provincial
cancer registry and the BCCA medical records, both of
which have high quality [32]. Essentially all radiotherapy
services in BC are provided by the BCCA, as well as a
majority of chemotherapy services. The BCCA operates
five regional cancer care centers and provides clinics in
remote areas. The population of BC is ethnically diverse
and well placed for a study of ethnic differences in treat-
ment. The sizes of the three minority groups in this
study were large.
There are also limitations to our study. Ethnicity was
not recorded in BCCR or BCCA records and had to be
determined using surnames. Information about disease
stage and treatment was only available for BCCA-
referred patients; hence the need to limit the study to
these patients. Information about whether a woman
received mastectomy or breast-conserving surgery was
not available for any patients and this prevents us from
determining whether the use of radiation accompanying
surgery was appropriate. Another limitation was the lack
of information about treatment decision making from
both the patient’sa n dp h y s i c i a n ’s perspectives. Our
study was a retrospective analysis of patient records in a
large cancer registry. The complete rationale that a
patient or physician based his or her choice of treatment
is not recorded. Finally, we did not consider the extent
to which patients completed treatments, although it
would be difficult to determine the reasons for this
using retrospective data.
Conclusions
We found that Chinese women with stage I or II breast
cancer are significantly less likely to receive surgery with
radiation than South Asian and Iranian women. In con-
trast, Chinese women with stage I or stage II breast can-
cer are significantly more likely to receive surgery
without radiation. Treatment with chemotherapy or hor-
mone therapy did not differ between these groups. Like
other studies [5], we found no significant change in eth-
nic disparities during recent years.
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by ethnicity, which has received little attention to date.
The description of these differences is the first step to
guiding interventions to reduce ethnic disparities. Future
studies need to examine reasons for these differences,
including the decision making process, culture and
beliefs of both the patient and physician.
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